Xiaoming Hou

1.1k total citations
60 papers, 747 citations indexed

About

Xiaoming Hou is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaoming Hou has authored 60 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 18 papers in Oncology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaoming Hou's work include Lung Cancer Treatments and Mutations (8 papers), MicroRNA in disease regulation (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Xiaoming Hou is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), MicroRNA in disease regulation (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Xiaoming Hou collaborates with scholars based in China, United States and Canada. Xiaoming Hou's co-authors include Da Zhao, Tao Zhang, Xinan Wu, Xiaojun Liu, Xiaoling Ling, Fei Su, Zhiguang Su, Xiangjin Li, Dongming Zhang and Jiangying Kuang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Xiaoming Hou

50 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoming Hou China 19 382 207 175 126 111 60 747
Joanna Boncela Poland 19 363 1.0× 209 1.0× 165 0.9× 96 0.8× 105 0.9× 43 755
Xiaoyi Wang China 18 549 1.4× 298 1.4× 182 1.0× 114 0.9× 120 1.1× 39 918
Dauren Biyashev United States 15 484 1.3× 268 1.3× 177 1.0× 92 0.7× 171 1.5× 27 855
Zhiming Zhang China 17 580 1.5× 238 1.1× 158 0.9× 68 0.5× 108 1.0× 53 889
Wanling Lin China 5 392 1.0× 131 0.6× 159 0.9× 79 0.6× 79 0.7× 7 701
Aytekin Akyol Türkiye 14 464 1.2× 151 0.7× 313 1.8× 95 0.8× 91 0.8× 40 964
Evelyn Aranda United States 11 412 1.1× 126 0.6× 210 1.2× 55 0.4× 106 1.0× 12 753
Kalliopi Tzavlaki Sweden 6 445 1.2× 144 0.7× 139 0.8× 69 0.5× 89 0.8× 7 742
Qilin Ao China 12 268 0.7× 161 0.8× 124 0.7× 219 1.7× 69 0.6× 43 689
Daofeng Tian China 18 459 1.2× 232 1.1× 125 0.7× 139 1.1× 113 1.0× 47 862

Countries citing papers authored by Xiaoming Hou

Since Specialization
Citations

This map shows the geographic impact of Xiaoming Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoming Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoming Hou more than expected).

Fields of papers citing papers by Xiaoming Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoming Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoming Hou. The network helps show where Xiaoming Hou may publish in the future.

Co-authorship network of co-authors of Xiaoming Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoming Hou. A scholar is included among the top collaborators of Xiaoming Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoming Hou. Xiaoming Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Tao, Ruoqi Wang, Yu-Bin Yang, et al.. (2025). KLF5 facilitates lung adenocarcinoma metastasis by regulating the epithelial-mesenchymal transition pathway through RHPN2. Journal of Translational Medicine. 23(1). 1078–1078.
2.
Yang, Gang, et al.. (2024). HNF1A induces glioblastoma by upregulating EPS8 and activating PI3K/AKT signaling pathway. Biochemical Pharmacology. 223. 116133–116133. 1 indexed citations
3.
Wang, Jie, Zhehai Wang, Yao Yu, et al.. (2024). Efficacy and safety of MCLA-129, an EGFR/c-MET bispecific antibody, in advanced non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 42(16_suppl). 8604–8604. 5 indexed citations
4.
5.
Zhang, Tao, Fei Su, Bofang Wang, et al.. (2024). Ubiquitin specific peptidase 38 epigenetically regulates KLF transcription factor 5 to augment malignant progression of lung adenocarcinoma. Oncogene. 43(16). 1190–1202. 9 indexed citations
6.
Zhao, Lihong, Mei Li, Chen Shen, et al.. (2024). Nano-Assisted Radiotherapy Strategies: New Opportunities for Treatment of Non-Small Cell Lung Cancer. Research. 7. 429–429. 16 indexed citations
7.
8.
Wei, Kai, et al.. (2023). Potential of metagenomic next-generation sequencing in detecting infections of ICU patients. Molecular and Cellular Probes. 68. 101898–101898. 2 indexed citations
9.
Li, Wenqiang, Mei Li, Xiaoyu He, et al.. (2023). Advancement of regulating cellular signaling pathways in NSCLC target therapy via nanodrug. Frontiers in Chemistry. 11. 1251986–1251986. 1 indexed citations
10.
Shen, Chen, Mei Li, Xin Jiang, et al.. (2023). HDAC inhibitors enhance the anti-tumor effect of immunotherapies in hepatocellular carcinoma. Frontiers in Immunology. 14. 1170207–1170207. 17 indexed citations
11.
12.
Duan, Ling, et al.. (2022). Identification of Autophagy-Related LncRNA to Predict the Prognosis of Colorectal Cancer. Frontiers in Genetics. 13. 906900–906900. 8 indexed citations
13.
Yu, Tingting, Tao Zhang, Fei Su, et al.. (2021). ELK1 Promotes Epithelial‐Mesenchymal Transition and the Progression of Lung Adenocarcinoma by Upregulating B7‐H3. Oxidative Medicine and Cellular Longevity. 2021(1). 2805576–2805576. 16 indexed citations
14.
Hou, Xiaoming, et al.. (2020). Exosome-based Tumor Therapy: Opportunities and Challenges. Current Drug Metabolism. 21(5). 339–351. 19 indexed citations
15.
Su, Fei, Fenfang Zhou, Tao Zhang, et al.. (2020). Quantitative proteomics identified 3 oxidative phosphorylation genes with clinical prognostic significance in gastric cancer. Journal of Cellular and Molecular Medicine. 24(18). 10842–10854. 17 indexed citations
16.
17.
Ling, Xiaoling, et al.. (2019). MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1. Breast Cancer. 26(6). 817–825. 56 indexed citations
18.
Hou, Xiaoming, Tao Zhang, Da Zhao, & Xinan Wu. (2019). CHPF promotes lung adenocarcinoma proliferation and anti-apoptosis via the MAPK pathway. Pathology - Research and Practice. 215(5). 988–994. 31 indexed citations
19.
Zhang, Tao, et al.. (2014). The prognostic value of osteopontin expression in non-small cell lung cancer: a meta-analysis. Journal of Molecular Histology. 45(5). 533–540. 20 indexed citations
20.
Kuang, Jiangying, et al.. (2014). Identification of insulin as a novel retinoic acid receptor‐related orphan receptor α target gene. FEBS Letters. 588(6). 1071–1079. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joanna Boncela Breakdown of academic impact, for papers by Xiaoyi Wang Breakdown of academic impact, for papers by Dauren Biyashev Breakdown of academic impact, for papers by Zhiming Zhang Breakdown of academic impact, for papers by Wanling Lin Breakdown of academic impact, for papers by Aytekin Akyol Breakdown of academic impact, for papers by Evelyn Aranda Breakdown of academic impact, for papers by Kalliopi Tzavlaki Breakdown of academic impact, for papers by Qilin Ao Breakdown of academic impact, for papers by Daofeng Tian
Rankless by CCL
2026